Mgr. Lenka Košťálová
Technician, Marek Mráz Research Group
office: bldg. E35/281
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 7500 |
---|---|
e‑mail: |
Total number of publications: 31
2022
-
GAB1 as novel therapeutic target in B lymphoid and myeloid malignancies
Year: 2022, type: Conference abstract
-
Modelling chronic lymphocytic leukaemia microenvironment.
Year: 2022, type: Conference abstract
-
The role of long non-coding RNAs in BCR-mediated CLL activation.
Year: 2022, type: Conference abstract
2021
-
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia
Blood, year: 2021, volume: 138, edition: 9, DOI
-
FoxO1-GAB1 Axis Regulates Homing Capacity and Tonic AKT Activity in Chronic Lymphocytic Leukemia: Novel Therapeutic Target.
Year: 2021, type: Conference abstract
-
GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.
Year: 2021, type: Conference abstract
-
GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target
Year: 2021, type: Conference abstract
-
GAB1 reguluje tonickou AKT signalizaci a migraci buněk chronické lymfatické leukémie: implikace pro kombinační léčbu s BCR inhibitory.
Year: 2021, type: Conference abstract
-
Ibrutinib Blocks CD40 Signalling in CLL in Vivo by Reducing TRAF4 Levels.
Year: 2021, type: Conference abstract
-
miR-29 influences CD40 signaling in chronic lymphocytic leukemia (CLL): and axis affected by BCR inhibitors.
Year: 2021, type: Conference abstract